Prescribing patterns of buprenorphine waivered physicians
DATA 2000 enabled physicians with approved training to be waivered to prescribe buprenorphine for the treatment of opioid use disorders (OUD) for a limited number of patients. A rule change in 2016 increased the patient limit for certain buprenorphine waivered physicians from 100 to 275. This study examines the prescribing patterns of buprenorphine prescribers by […]
Steering Committee Meets to Discuss Strategy
Members of the PCSS Steering Committee met last week in Washington, D.C., energized and motivated to strategize and brainstorm for the coming year. The overall goal of the meeting was to share what PCSS has accomplished in the past year, discuss proposed activities, and create a strategic plan for the future. The objective was to […]
Advanced Studies Essentials of Addiction Medicine Course – Oct 28th to 29th
The AOAAM will offer an Essential of Addiction Medicine Course on October 28 and 29, 2017 in Lansing, Michigan. The two-day course will cover fundamentals in addiction medicine and offer 16 hours of AOA Category 1-A CME. This course is designed to provide up-to-date data and practice techniques for basic through advanced addiction treatment, and […]
The American Congress of Obsetetricians and Gynecologists (ACOG) Issues Guidelines on Opioid Use During Pregnancy
A free subscription to Medscape is required to complete this CME/ABIM MOC/CE activity. Join Medscape › The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care. Upon completion of this activity, participants will be able to: Evaluate recommendations for screening for […]
Patient Outcomes in Dose Reduction or Discontinuation of Long-Term Opioid Therapy: A Systematic Review
Expert guidelines recommend reducing or discontinuing long-term opioid therapy (LTOT) when risks outweigh benefits, but evidence on the effect of dose reduction on patient outcomes has not been systematically reviewed. Read abstract ›
Medical Student Creates Pilot for Making MAT Waiver Training Part of UMASS Medical School Curriculum
Lily Rabinow, MS, a medical doctorate candidate at the University of Massachusetts Medical School (UMMS), recognized the need for physicians, in particular pediatricians, to be better trained in treating opioid use disorders with the use of medications.
Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population
We investigated prescribing patterns for five opioid use disorder (OUD) medications: 1) injectable naltrexone, 2) oral naltrexone, 3) sublingual or oromucosal buprenorphine/naloxone, 4) sublingual buprenorphine, and 5) transdermal buprenorphine in a nationally representative claims-based database (Truven Health MarketScan®) of commercially insured individuals in the United States. We calculated the prevalence of OUD in the database […]
An Evidence-Based Recommendation to Increase the Dosing Frequency of Buprenorphine During Pregnancy
Dose-adjusted plasma concentrations of buprenorphine are significantly decreased during pregnancy compared to the non-pregnant state. This observation suggests that pregnant women may need a higher dose of buprenorphine than non-pregnant individuals in order to maintain similar drug exposure (plasma concentrations over time after a dose). The current dosing recommendations for buprenorphine during pregnancy address the […]
Closing the Medication-Assisted Treatment Gap for Youth With Opioid Use Disorder
In years past, an adolescent patient presenting to primary care with symptoms of opioid use disorder (OUD) would have been a highly rare event in most communities. With OUD and fatal overdoses rising among adolescents and young adults (termed youth) over the past 15 years, this scenario has unfortunately become more common. Fatal drug overdoses […]
Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome
Current pharmacologic treatment of the neonatal abstinence syndrome with morphine is associated with a lengthy duration of therapy and hospitalization. Buprenorphine may be more effective than morphine for this indication. Read abstract ›
